1998
Lack of Association Between Antiphospholipid Antibodies and First-Trimester Spontaneous Abortion: Prospective Study of Pregnancies Detected Within 21 Days of Conception 11Supported by grants and contracts from the National Institute of Child Health and Human Development, National Institutes of Health.
Simpson J, Carson S, Chesney C, Conley M, Metzger B, Aarons J, Holmes L, Jovanovic-Peterson L, Knopp R, Mills J. Lack of Association Between Antiphospholipid Antibodies and First-Trimester Spontaneous Abortion: Prospective Study of Pregnancies Detected Within 21 Days of Conception 11Supported by grants and contracts from the National Institute of Child Health and Human Development, National Institutes of Health. Fertility And Sterility 1998, 69: 814-820. PMID: 9591485, DOI: 10.1016/s0015-0282(98)00054-5.Peer-Reviewed Original ResearchConceptsAntiphospholipid antibodiesAnticardiolipin antibodiesPregnancy lossProspective studyFirst trimester pregnancy lossEnzyme immunoassayFirst-trimester spontaneous abortionsFirst trimester lossNational InstituteLack of associationDay of conceptionFetal deathRetrospective studySpontaneous abortionLive birthsMAIN OUTCOMEChild healthSuch antibodiesBlood samplesPregnancyMulticenter universityAntibodiesSerumWomenSelection bias
1996
Prospective study showing that antisperm antibodies are not associated with pregnancy losses**Supported by a contract with the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Simpson J, Carson S, Mills J, Conley M, Aarons J, Holmes L, Jovanovic-Peterson L, Knopp R, Metzger B. Prospective study showing that antisperm antibodies are not associated with pregnancy losses**Supported by a contract with the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. Fertility And Sterility 1996, 66: 36-42. PMID: 8752608, DOI: 10.1016/s0015-0282(16)58384-8.Peer-Reviewed Original ResearchConceptsIgM antisperm antibodiesAntisperm antibodiesPregnancy lossIgA antisperm antibodiesNondiabetic womenPregnancy outcomesPositive findingsFirst trimester pregnancy lossTrimester pregnancy lossFirst-trimester serumIndirect immunobead testNational InstituteOnly positive findingDay of conceptionMaternal serumClinical statusProspective studyImmunobead testLiveborn infantsProspective dataChild healthPositive testIgM bindingRegional bindingLocation of antibody
1991
Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall T, Ling F, Gray L, Carson S, Buster J. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstetrics And Gynecology 1991, 77: 749-53. PMID: 2014090.Peer-Reviewed Original ResearchConceptsUnruptured ectopic pregnancyEctopic pregnancyConservative surgical proceduresHCG titerPatient nosPrimary therapySurgical proceduresSide effectsPrevious ectopic pregnancyRecurrent ectopic pregnancyIdentifiable risk factorsOngoing clinical trialsCardiac activityTubal pregnancyPersistent diseaseFourth doseMedical therapyMethotrexate treatmentOutpatient protocolInvolved sideTubal patencyRisk factorsClinical trialsPregnancyPatients
1983
Heritable aspects of uterine anomalies. I. Three familial aggregates with Müllerian fusion anomalies**Supported in part by NIH grants HD 11021 and HD 02841, and grants from the March of Dimes.
Verp M, Simpson J, Elias S, Carson S, Sarto G, Feingold M. Heritable aspects of uterine anomalies. I. Three familial aggregates with Müllerian fusion anomalies**Supported in part by NIH grants HD 11021 and HD 02841, and grants from the March of Dimes. Fertility And Sterility 1983, 40: 80-85. PMID: 6862042, DOI: 10.1016/s0015-0282(16)47181-5.Peer-Reviewed Original Research